ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684496 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684496; 2) Community: the network communities that were significantly associated with the response to NSC 684496; 3) Molecule: the relationships between components within communities and NSC 684496; 4) MDR: the compounds that were significantly associated with the NSC 684496.

NSC Compound Enrichment Correlation
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.12211489
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.7327736
NSC 371777 Null 0.0385613993886001 0.1088767
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.73327312
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0385613993886001 0.43289463
NSC 601518 Null 0.0385613993886001 0.69949931
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0385613993886001 -0.25686851
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.27851265
NSC 608329 Null 0.0385613993886001 -0.035066997
NSC 617394 Null 0.0385613993886001 0.47628012
Total:107  Current:73    [First] [Prev] [Next] [Last]